$3.25
-0.02-0.61%
Pre-Market: 7:26 AM EDT
15 minutes delayed
Editas Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Editas Medicine using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.82 | $-0.70 | -17.1 % |
Mar 2024 | 2024-05-08 | $-0.76 | $-0.67 | -13.4 % |
Dec 2023 | 2024-02-28 | $-0.23 | $-0.54 | 57.4 % |
Sep 2023 | 2023-11-03 | $-0.55 | $-0.57 | 3.51 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $513.00K | $5.08M | -89.9 % |
Mar 2024 | 2024-05-08 | $1.14M | $7.90M | -85.6 % |
Dec 2023 | 2024-02-28 | $60.05M | $7.94M | 656.3 % |
Sep 2023 | 2023-11-03 | $5.34M | $3.42M | 56.0 % |
Editas Medicine (EDIT) is scheduled to report earnings on November 1, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.82, which missed the estimate of $-0.70.
The Actual Revenue was $513K, which missed the estimate of $5.1M.
Browse earnings estimates, EPS, and revenue on all stocks.